This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Innovations by Chapman M Wright
Introduction
Chapman M Wright is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 2 patents, Wright's work focuses on the activation of prodrugs in cancer cells using molecular switches.
Latest Patents
Wright's latest patents include a groundbreaking invention that features a novel protein engineering strategy. This strategy combines the domains of two independent proteins into a molecular switch. The invention includes polypeptides that comprise a prodrug activating enzyme and a protein that binds to a cancer-specific marker. Additionally, it encompasses polynucleotides encoding these polypeptides and molecular switches that convert a prodrug into a toxin. The invention also outlines methods for converting a prodrug into a toxin, methods for treating cancer, and methods for creating the molecular switches, along with associated kits.
Career Highlights
Wright is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Wright collaborates with Marc Alan Ostermeier, contributing to the development of innovative solutions in the field of cancer treatment.
Conclusion
Chapman M Wright's contributions to cancer research through his innovative patents highlight the importance of scientific advancements in medical treatments. His work exemplifies the potential of combining protein engineering with therapeutic applications.